AstraZeneca's Principles for Product-Related Online Communications
Industry anticipates meaningful guidance from FDA on use of social media
How Well Can Biopharma Protect Itself Against Theft?
Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of Capital
Investment funds have developed an interest in trading capital for royalties on drug commercializations
Look for Flexibility In Your CRM or SFA System
Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?
True Software-as-a-Service (SaaS) Transforms Sales Automation Systems to Make Upgrades Painless
Multi-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment
Optimization of 2-8 Degrees Celsius Controlled-Temperature Small Parcels
Leveraging the EHR to Advance Clinical Research
Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety
Injectable-Drug Market Continues Moving Toward Plastics and Prefilled Syringes
Parenteral (injectable) drugs gain user acceptance even as biotech brings more of them onto the market
Get Ready for Pharma 3.0, Says Ernst & Young in Its Annual Progressions Report
The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients
Industry Sets Its Social-Media Regulatory Position With DDMAC
PhRMA pushes for an FDA ‘universal symbol’ of approved content, and seeks latitude in communications in online forums
Global Growth Will Accelerate in 'Pharmerging' Countries, Says IMS Health
Big Pharma is not yet deeply enough invested in faster-growing markets outside the developed economies
SupplyScape, reborn as TraceLink, is back with the
Pedigree-pioneering team resurfaces with cloud-based collaborative platform
Today's global biopharma cold-chain market is $5.1 billion, growing to $6.6 billion by 2011
FDA's DDMAC Takes Another Stab at Enforcing Fair Balance in Drug Advertising
Agency strives to balance risks and benefits in how drugs are presented in direct-to-consumer (DTC) campaigns
What the iPad Means for Pharma
New Apple gadget could help usher in an era of medical applications fully integrated into a healthcare professional’s day-to-day life
US Prescription Sales Grew 5.1% in 2009 to $300.3 billion, Estimates IMS Health
Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%
Pharmaceutical Shippers' Preparations for 100% Cargo Screening Move Forward
Public Thinks Less of Pharmaceutical Industry in 2009
In latest Harris Interactive study, reputation of the pharmaceutical industry drops, but still fares better than some sectors
Mega-Mergers Affect Real Estate Landscape for Pharma
FDA unveils its Serial Numeric Identifier (SNI) guidance for encoding pharma packages
Code would include NDC number; GS1 coding structure gets a nod
Eli Lilly suffers $75-million burglary of branded products stolen from a Connecticut warehouse
Company says affected lots will no longer be distributed
Industry reaction to federal healthcare reform is mixed
Medication adherence could get an EHR boost
Growing digitization of patient data could break the threshold to better adherence to medication therapies
Sampling package optimization wins HDMA award
AmerisourceBergen Packaging and Pfizer partner to develop a cost-effective starter pack for Toviaz tablets
More European serialization projects test barcodes' utiity
EFPIA wraps up its 2009 test; a new pilot in the UK with Reckett-Benckiser
Preparing the Market for a New Drug with an Effective 'Medical Affairs Launch'
The Medical Affairs function can play a vital role in today’s product launch process
Smartphone Adoption Has Reached 30% Among Office-Based Physicians, Says SDI Health
Over half of all physicians are participating in social-media sites or online professional networks
Improving Outcomes Research Protocols
Brand Protection Technology Takes a Patient-Communication Turn
How the many anticounterfeiting measures on the market today could turn into a means of connecting with patients
OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?
Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers
